These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1551566)

  • 1. Azathioprine or 6-mercaptopurine therapy and colon carcinoma in Crohn's disease.
    Zelig MP; Choi PM
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1448. PubMed ID: 1551566
    [No Abstract]   [Full Text] [Related]  

  • 2. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Prefontaine E; Macdonald JK; Sutherland LR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD000545. PubMed ID: 19821270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of the workshop on 6-mercaptopurine/azathioprine pharmacology.
    Markowitz JF
    Inflamm Bowel Dis; 1998 May; 4(2):117-8; discussion 118-20. PubMed ID: 9687220
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
    Bouhnik Y; Lémann M; Mary JY; Scemama G; Taï R; Matuchansky C; Modigliani R; Rambaud JC
    Lancet; 1996 Jan; 347(8996):215-9. PubMed ID: 8551879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azathioprine-induce acute submandibular sialadenitis in a patient with Crohn's disease.
    Guerra Romero A; Pérez Calle JL; López Serrano P
    Gastroenterol Hepatol; 2018 Nov; 41(9):570-571. PubMed ID: 29150359
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease.
    O'Brien JJ; Bayless TM; Bayless JA
    Gastroenterology; 1991 Jul; 101(1):39-46. PubMed ID: 2044925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TPMT in the treatment of Crohn's disease with azathioprine.
    Lennard L
    Gut; 2002 Aug; 51(2):143-6. PubMed ID: 12117866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine and 6-mercaptopurine have a role in the treatment of Crohn's disease.
    Lennard-Jones JE
    Dig Dis Sci; 1981 Apr; 26(4):364-8. PubMed ID: 7016483
    [No Abstract]   [Full Text] [Related]  

  • 9. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Prefontaine E; Sutherland LR; Macdonald JK; Cepoiu M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000067. PubMed ID: 19160175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azathioprine and 6-mercaptopurine for Crohn's disease.
    Lancet; 1980 Aug; 2(8189):298-9. PubMed ID: 6105443
    [No Abstract]   [Full Text] [Related]  

  • 11. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis.
    Pearson DC; May GR; Fick GH; Sutherland LR
    Ann Intern Med; 1995 Jul; 123(2):132-42. PubMed ID: 7778826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of 6-mercaptopurine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: balance.
    Jacobstein DA; Baldassano RN
    Inflamm Bowel Dis; 2005 Feb; 11(2):203-5. PubMed ID: 15677916
    [No Abstract]   [Full Text] [Related]  

  • 14. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].
    Schreiber S
    Dtsch Med Wochenschr; 2013 Sep; 138(38):1877. PubMed ID: 24022448
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease.
    Sultan K; Korelitz BI; Present D; Katz S; Sunday S; Shapira I
    Inflamm Bowel Dis; 2012 Oct; 18(10):1855-8. PubMed ID: 22241664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease.
    Sandborn W; Sutherland L; Pearson D; May G; Modigliani R; Prantera C
    Cochrane Database Syst Rev; 2000; (2):CD000545. PubMed ID: 10796557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon.
    van Geenen EJ; de Boer NK; Stassen P; Linskens RK; Bruno MJ; Mulder CJ; Stegeman CA; van Bodegraven AA
    Aliment Pharmacol Ther; 2010 Jun; 31(12):1322-9. PubMed ID: 20222913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease.
    Korelitz BI; Present DH
    J Crohns Colitis; 2014 Aug; 8(8):735-8. PubMed ID: 24462321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of 6-mercapturine/azathioprine as the immunomodulator of choice for moderately active Crohn's disease: con.
    Griffiths AM
    Inflamm Bowel Dis; 2005 Feb; 11(2):200-2. PubMed ID: 15677915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.